Bin Qiao
- Oncology top 10%
- Cancer Cells and Metastasis 9
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism 3
- Otorhinolaryngology top 10%
-
- Cancer-related gene regulation 4
- RNA modifications and cancer 4
-
- COVID-19 Clinical Research Studies 4
- SARS-CoV-2 and COVID-19 Research 3
-
- Telomeres, Telomerase, and Senescence 3
-
- Cancer Research and Treatments 3
- Co-authors
- Alfred K. LamZi MeiJunwen HuangFarhadul IslamVinod GopalanRobert A. SmithQian TaoFengchun Hu
- Partner nations
- ChinaAustraliaUnited States
In The Last Decade
Bin Qiao
34 papers receiving 869 citations
Peers
Comparison fields: 5 of 88
- Oncology 353
- Cancer Research 188
- Otorhinolaryngology 44
- Molecular Biology 408
- Immunology 125
Countries citing papers authored by Bin Qiao
This map shows the geographic impact of Bin Qiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bin Qiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bin Qiao more than expected).
Fields of papers citing papers by Bin Qiao
This network shows the impact of papers produced by Bin Qiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bin Qiao. The network helps show where Bin Qiao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bin Qiao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2022 | 3 | |
| 3 | 2021 | 4 | |
| 4 | 2020 | 171 | |
| 5 | 2020 | 33 | |
| 6 | 2020 | 17 | |
| 7 | 2020 | 18 | |
| 8 | 2020 | 21 | |
| 9 | 2017 | 24 | |
| 10 | 2017 | 6 | |
| 11 | 2017 | 5 | |
| 12 | 2016 | 15 | |
| 13 | 2016 | 4 | |
| 14 | 2015 | 89 | |
| 15 | 2014 | 17 | |
| 16 | 2014 | 12 | |
| 17 | 2013 | 26 | |
| 18 | 2012 | 21 | |
| 19 | 2009 | 25 | |
| 20 | 2009 | 9 |
About Bin Qiao
Bin Qiao is a scholar working on Oncology, Cancer Research and Biotechnology, having authored 36 papers that have together received 874 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (9 papers), COVID-19 Clinical Research Studies (4 papers), Cancer-related gene regulation (4 papers), RNA modifications and cancer (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Telomeres, Telomerase, and Senescence (3 papers), Cancer Research and Treatments (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). The work is most often cited by research in Oncology (353 citations), Cancer Research (188 citations) and Otorhinolaryngology (44 citations). Bin Qiao has collaborated with scholars based in China, Australia and United States. Frequent co-authors include Alfred K. Lam, Zi Mei, Junwen Huang, Farhadul Islam, Vinod Gopalan, Robert A. Smith, Qian Tao, Fengchun Hu, Baoxia He and Jinghua Cai. Their work appears in journals such as Circulation, PLoS ONE and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.